UroGen Pharma
URGN
URGN
63 hedge funds and large institutions have $413M invested in UroGen Pharma in 2018 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 25 increasing their positions, 19 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
63
Holders Change
-8
Holders Change %
-11.27%
% of All Funds
1.41%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
9
Increased
25
Reduced
19
Closed
15
Calls
$348K
Puts
–
Net Calls
+$348K
Net Calls Change
+$707K
Top Buyers
1 |
WCM
Wildcat Capital Management
New York
|
+$10.2M |
2 |
BlackRock
New York
|
+$8.5M |
3 |
HCM
Highline Capital Management
New York
|
+$5.59M |
4 |
CI
Clal Insurance
Tel-Aviv,
Israel
|
+$3.84M |
5 |
DG
Delek Group
Herzliya,
Israel
|
+$2.82M |